[1]
Q. Liang, Q. Fu, W. Li, J. You, and Z. Zhao, “Lapatinib, trastuzumab or the combination added to neoadjuvant chemotherapy for breast cancer”, Bangladesh J Pharmacol, vol. 11, no. 4, pp. 863–868, Oct. 2016.